Skip to main content
. 2006 Jul 31;103(32):12121–12126. doi: 10.1073/pnas.0605134103

Table 2.

In vitro and in vivo characteristics of avian–human reassortant influenza viruses

Reassortant virus Avian or human virus gene*
EID50/ml, log10 pfu/ml No. of inoculated ferrets/total number
Peak nasal wash titer (day)§
PB2 PB1 PA HA NP NA M NS Weight loss (%) Sneezing (day of onset) Virus detected in nasal wash (days p.i.)
rgVic H H H H H H H H 9.3 5 × 106 2/3 (1.4) 3/3 (2) 3/3 (1–7) 5.1 (1)
rg486 A A A A A A A A 7.5 5 × 105 3/3 (21.1) 0/3 3/3 (1–7+) 6.2 (5)
rgVic:486HANA H H H A H A H H 7.8 1 × 103 1/3 (2.2) 0/3 3/3 (1–7+) 3.7 (3)
rg486:VicHANA A A A H A H A A 7.8 4 × 106 3/3 (4.1) 3/3 (2) 3/3 (1–5) 5.2 (3)
rg486:VicRNP H H H A H A A A 7.5 1 × 107 2/3 (1.7) 0/3 3/3 (1–5) 4.7 (3)
rg486:VicRNPF5 H H H A H A A A 8.3 4 × 107 3/3 (0.3) 2/3 (7) 3/3 (1–5) 5.1 (3)

*Avian genes (A) are from HK486 (H5N1), and human genes (H) are from Vic75 (H3N2) virus.

The percentage mean maximum weight loss is shown.

+, the endpoint of virus detection in nasal washes was not determined for all ferrets.

§Peak nasal wash titers are expressed as the mean log10 EID50/ml.

rg486:VicRNP was passaged five times in ferrets and then grown in eggs.